AFT Pharmaceuticals Limited

CHIA:AFP Stock Report

Market Cap: AU$274.5m

AFT Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Hartley Atkinson

Chief executive officer

NZ$974.8k

Total compensation

CEO salary percentage68.7%
CEO tenure27.3yrs
CEO ownership68.7%
Management average tenureno data
Board average tenure6.8yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Hartley Atkinson's remuneration changed compared to AFT Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

NZ$12m

Jun 30 2024n/an/a

NZ$14m

Mar 31 2024NZ$975kNZ$670k

NZ$16m

Dec 31 2023n/an/a

NZ$13m

Sep 30 2023n/an/a

NZ$11m

Jun 30 2023n/an/a

NZ$11m

Mar 31 2023NZ$931kNZ$606k

NZ$11m

Dec 31 2022n/an/a

NZ$14m

Sep 30 2022n/an/a

NZ$17m

Jun 30 2022n/an/a

NZ$18m

Mar 31 2022NZ$840kNZ$578k

NZ$20m

Dec 31 2021n/an/a

NZ$15m

Sep 30 2021n/an/a

NZ$11m

Jun 30 2021n/an/a

NZ$9m

Mar 31 2021NZ$701kNZ$506k

NZ$8m

Dec 31 2020n/an/a

NZ$5m

Sep 30 2020n/an/a

NZ$3m

Jun 30 2020n/an/a

NZ$7m

Mar 31 2020NZ$592kNZ$443k

NZ$12m

Dec 31 2019n/an/a

NZ$11m

Sep 30 2019n/an/a

NZ$11m

Jun 30 2019n/an/a

NZ$4m

Mar 31 2019NZ$556kNZ$431k

-NZ$3m

Dec 31 2018n/an/a

-NZ$7m

Sep 30 2018n/an/a

-NZ$11m

Jun 30 2018n/an/a

-NZ$12m

Mar 31 2018NZ$514kNZ$429k

-NZ$14m

Compensation vs Market: Hartley's total compensation ($USD546.96K) is about average for companies of similar size in the Australian market ($USD675.93K).

Compensation vs Earnings: Hartley's compensation has been consistent with company performance over the past year.

CEO

Hartley Atkinson

27.3yrs

Tenure

NZ$974,785

Compensation

Dr. Hartley Atkinson, M.Pharm (Dist), PhD, is Co-Founder of AFT Pharmaceuticals Limited in 1997. Dr. Atkinson is Chief Executive Officer of AFT Pharmaceuticals Limited since September 04, 1997 and also ser...

Board Members

NamePositionTenureCompensationOwnership
Hartley Atkinson
Co-Founder27.3yrsNZ$974.79k68.7%
A$ 188.6m
Marree Atkinson
Co-Founder12.3yrsNZ$175.44kno data
Theodore Witek
Independent Non-Executive Director4.1yrsNZ$161.04kno data
David Flacks
Independent Chairman9.6yrsNZ$154.00k0.17%
A$ 468.0k
Andrew Lane
Independent Non-Executive Director1.3yrsNZ$50.38k0.091%
A$ 248.7k
Allison Yorston
Independent Non-Executive Directorless than a yearno datano data

6.8yrs

Average Tenure

Experienced Board: AFP's board of directors are considered experienced (6.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 14:03
End of Day Share Price 2024/12/13 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AFT Pharmaceuticals Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Jack CrowleyCredit Suisse
Soo RomanoffEdison Investment Research